Concepedia
Statistics
Publications
3
Citations
153
H-Index
Active since
2020
Affiliations
Methodist Hospital(Current)
Texas A&M Health Science Center
Houston Methodist
University of California, Los Angeles
Ann C. Anselme is an author at Methodist Hospital specializing in pharmacology, molecular oncology, and medicine.
Publications per year
2020–2022
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer
Andrew W. Chung, Kartik Anand, Ann C. Anselme et al. · Science Translational Medicine · 2021 · 109 citations
Medicine, Oncology, Pharmacology +10
Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6
Andrew W. Chung, Anthony J. Kozielski, Wei Qian et al. · npj Breast Cancer · 2022 · 30 citations · Full text
Medicine, Oncology, Pharmacology +17
Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs
T. P. Reddy, Dong S. Choi, Ann C. Anselme et al. · Breast Cancer Research · 2020 · 14 citations · Full text
Medicine, Oncology, Pharmacology +15
1–3 of 3